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A marked enhancement of anti-hapten antibody synthesis in response to immuni- 
zation with a hapten-protein conjugate occurs as a result of pre-immunization of ani- 
mals with  unmodified  carrier.  This  is  true  both  for primary  and  secondary  anti- 
hapten  responses  and  is  most  strikingly  demonstrated  when  an  animal  which has 
received a primary immunization with a hapten conjugate of a given carrier is boosted 
with the same hapten conjugated to a different carrier, to which the animal has been 
preimmunized  (1-6). 
This phenomenon indicates the existence of independent recognition units for hap- 
ten and for carrier.  Cooperative interaction between these units may be essential to 
the production of an anti-hapten  antibody response,  or may amplify a  modest im- 
mune response which occurs in the absence of carrier-specific recognition. 
An understanding of the nature of the carrier recognition unit and of the range of 
substances which it recognizes and acts upon is required in order to construct a  co- 
herent picture of cooperative interactions in the immune response. Studies presented 
both by Mitchison and Rajewsky, et al.  (4, 5) and those reported in the first paper of 
this series  (6) show that humoral antibody is not the carrier recognition unit. 
In the adoptive secondary antibody response in mice, hapten-carrier  cooperative 
interactions appear to be mediated by hapten-specific and carrier-specific lymphoid 
cells  (4,  7).  In the  present  communication we  show that live  lymphoid cells  from 
strain 2 guinea pigs immunized to bovine gamma globulin  (BGG)  enable  syngeneic 
animals immunized with 2,4-dinitrophenyl ovalbumin (DNP-OVA) to form a second- 
ary anti-DNP response to DNP-BGG. Thus, in both species  the carrier recognition 
unit appears to be associated with a lympboid cell. 
Several  relevant  questions  may  then  be  asked  concerning  the  significance 
of this phenomenon and the mechanism by which carrier-specific cells enhance 
anti-hapten  antibody response.  One suggested function  of the  carrier-specific 
cell  is  the  concentration  and presentation  of antigen  (4,  7).  Such cells would 
bind  multideterminant  antigens  by  one  of  their  determinants  and  simply 
present  other  determinants  to  appropriate  hapten-specific  cells  ill  certain 
anatomical  locations.  However,  the  possibility  must  also  be  considered  that 
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the carrier-specific cell  or its product exerts a  more sophisticated  and complex 
function which is concerned, in part,  with the recognition of certain classes of 
molecules,  such  as  proteins  or  polypeptides,  as  immunogens.  A  study  was 
therefore  made  of  the  kinds  of  substances  with  which  carrier  function  is  as- 
sociated and of the immunological specificity of this phenomenon. 
The results will show that: 
(a)  An antigen  such  as  a  copolymer of L-glutamic acid  and  L-lysine  (GL) 
to which a given strain of guinea pig is genetically unable to accord a complete 
immune  response  does  not  function  as  a  carrier  in  that  strain;  on  the  other 
sensitization  to  a  simple  carrier,  poly-L-lysine  (PLL),  does  prepare 
"responder"  guinea  pigs  for  an  augmented  secondary  response  to  a  hapten 
conjugate of PLL. 
(b)  Attempts  to  sensitize  animals to haptens by immunization with hapten 
conjugates of foreign proteins  fail  to prepare  for enhanced primary or second- 
dary  responses  to  other  determinants  associated  with  that  hapten  on  a  dif- 
ferent  carrier.  These  findings  indicate  that  hapten  alone  cannot  function 
specifically as  carrier  for other haptens  or,  in  other words,  that haptens  gen- 
erally  do  not  constitute  determinants  capable  of  being  recognized  by  cells 
concerned  with  carrier  function  or,  alternatively,  of  stimulating  such  cells 
to perform this function.  However,  haptens  may contribute  to  such  determi- 
nants;  hapten conjugates of  an autologous  protein,  such as  DNP-guinea  pig 
albumin,  may stimulate  the  formation  of carrier-specific  cells  capable  of en- 
hancing the antibody response to other haptens presented on the same molecule. 
(c)  The  capacity of carrier  preimmunization  to augment secondary respon- 
siveness  to  hapten-carrier  conjugates  is  abolished  by  specific  immunologic 
tolerance to that carrier. 
Materials and Methods 
Proteins and Chemical Reagents.--Guinea  pig albmnin  (GPA) was obtained  from Pentex 
Biochemicals, Kankakee,  IlL Glucose oxidase (GO), from Aspergillus  niger, was purchased 
from Sigma Chemical Co., St. Louis, Mo. Poly-L-lysine hydrobromide  (PLL), poly-D-lysine 
hydrobromide  (PDL) and the copolymer of L-glutamic acid and L-lysine (GL) were obtained 
from Pilot  Chemicals, Inc., Watertown,  Mass. Average molecular weights were respectively 
90,000, 140,000 and 115,000, and the GL had a ratio of G:L of 60:40.5<timethylaminonaph- 
thalene  sulfonyl  chloride  (DANSYL-CI) was  purchased  from  Calbiochem.,  Los  Angeles, 
Calif.  and  sulfanilic acid was obtained  from Fisher  Scientific Company,  Springfield, N.J. 
All other proteins and chemical reagents have been described in the preceding paper (6). 
Haptet~-carrier conjugates.--The  following 2,4-dinitrophenyl  conjugates were prepared  as 
previously described (6): DNPwOVA,  DNP2s-BGG, DNP24-GO, DNP27-GO, DNPa0-GPA, 
DNP35-PLL, DNPzs-PDL and DNP.20-GL. Subscripts refer to the average number of moles 
of I)NP per mole of carrier. 
p-azophenylsulfonic acid conjugates  of BGG and  GPA (Sulf-BGG and  Sulf-GPA) were 
prepared  as described by Campbell et al  (8). The degree of substitution,  calculated  on the 
basis of absorbancy at 460 m# in 0.1 N NaOH (e  =  9800) (9) and micro-Kjeldahl nitrogen 
analysis, was 29 and 30 moles of p-azophenylsulfonic acid per mole of BGG and GPA, respec- 
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DANSYL conjugates were prepared by the reaction, at alkaline pH, of DANSYL-C1 with 
the carriers. Weight ratios of DANSYL-Cl:carrier of 0.20 to 0.40 were employed; the reactions 
were carried out at room temperature and were allowed to proceed overnight. Conjugates were 
extensively dialyzed  against phosphate buffered saline  (PBS: 0.01  M potassium phosphate, 
0.15  M NaCI,  pH  7.6).  Degree  of  substitution was calculated from absorbancy at 330 m# 
(~  =  4570 for  ~-DANSYL-LYSINE)  (10)  and nitrogen content. The following conjugates 
were prepared: DANSYL39-GPA, DANSYL12-PLL, DANSYL2s-PLL and DANSYLsl-PDL. 
p-azophenylsulfonic acid conjugates of DNP  and DANSYL  proteins were prepared in a 
manner  similar  to  the preparation  of  Sulf-proteins.  Sulf16-DNP2wG0,  Sulf92-DNP24-GO, 
Sulf21-DNPa0-GPA and Sulflg-DANSYL39-GPA were prepared. 
DNP  conjugates of  DANSYL-polypeptides  were prepared  as  described  above. DNP23- 
DANSYL12-PLL  and DNP17~-DANSYLat-PDL  were synthesized. 
Preparation of radioactive compounds.--OVA was labeled with 125I by the reaction of 5 mg 
of OVA in 4.0 ml 0.1 M sodium carbonate, pH 9.5, with 2 mc of 125NaI in 0.15 ml of a solution 
of I2 in KI  (I2, 1.23 mg/ml; KI, 1.57 mg/ml) (11). The reaction was allowed to proceed for 1 
hr at 0°C; 125I-OVA was extensively dialyzed against PBS. All other radioactive compounds 
were prepared as described in the preceding paper (6). 
Immunizations.--Strain 2 and strain 13 inbred guinea pigs and New Zealand White rabbits 
were  immunized  according to  the  general  protocol  described  in  the  preceding  paper  (6) 
and outlined in the results section of this communication. 
Antibody measurements.--Serum concentrations of  anti-Sulf antibodies were  assayed  by 
passive  hemagglutination with sulfanil-azo-sheep erythrocytes prepared  by  the  method  of 
Ingraham  (12).  The  classical passive  hemagglutination procedure  was  followed  (13,  14). 
Antisera to be tested and normal sera used for diluents were decomplemented at 56°C  for 
30--60 rain and absorbed with washed sheep erythrocytes. The specificity of the reactions was 
verified by appropriate controls and by specific inhibition of hemagglutination with sulfanil- 
azochloroacetyl tyrosine. All tests were performed with microtiter equipment  (Cooke Engi- 
neering Co., Alexandria, Va.). The geometric mean of the reciprocal of the titers is presented. 
Anti-OVA antibody concentration was estimated by the Farr technique (15): 0.1  ml of 
antisera was mixed with 0.1 ml of a solution of ~25I-labeled OVA ,(10 #g/ml). After incubation 
at 37°C  for 1 hr, 0.4 ml of cold 66% saturated ammonium sulfate was added. Mter 30 rain 
at 4°C, the radioactivity of the total sample was measured. After centrifugation at 2500 rpm 
for 20 rain, 0.2  ml of each supernate was removed and radioactivity determined in a  NaI 
crystal scintillation counter. The percentage of binding of 12~I-OVA by each antiserum was 
calculated as follows: 
~o binding =  100  --  radioactivity of  0.2 ml  supernate 
Total radioactivity/3  (100) 
The serum concentrations of anti-DNP  antibodies and anti-BGG antibodies were meas- 
ured as described in the preceding paper (6). 
Statistical Analyses,--Serum antibody values were logarithmically transformed and means 
and standard errors calculated. Results from groups were compared by the Student's t test. 
RESULTS 
Ability of BGG-s pecific lymphoid cells to prepare DN P-O V A immunized guinea 
pigs for  a secondary  response  to DNP-BGG.--Strain  2  donor  guinea  pigs  were 
immunized  in the  footpads  with either  50/zg  of  BGG  emulsified  in  complete 
Freund's  adjuvant  (CFA)  or with saline in CFA.  3  wk later,  the animals were 
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spleen  were  removed.  Single  cell suspensions,  in minimum  essential  medium 
(Eagle),  were  prepared,  washed,  and  transferred  to  recipients;  a  varying 
number  of nucleated cells were injected intravenously into strain 2 guinea pig 
recipients which had been immunized 3 wk earlier with 3 daily doses of 1.0 mg 
of DNPT-OVA administered intraperitoneally in saline. 
Recipients were  boosted either  1  or 6  days after  cell transfer  with  1.0  mg 
of DNP2s-BGG  in saline  (200 #g intradermally followed by 800 ~g intraperi- 
TABLE I 
Enhancement  of Haplen-Specific  Anamnestic  Responses in  Guinea Pigs  Following Passive 
Transfer of Carrler-Specific Syngeneic Cells* 
Protocols  Anti-DNP antibody (.ug/ml)§ 
Number of  Boost[[ 
Group  Specificity of  Interval  animals 
cells transferred  (days)  Day 0  Day 7  Day It 
A  BGG  1  5  4.6  5.2  46.8  42.2 
B  CFA  1  5  5.0  0.90  11.8  6.8 
C  BGG  6  5  0.70  49.3  N.D.¶  48.6 
D  CFA  6  5  1.4  0.74  N.D.  0 
* 1 to 1.6 X  109 lymph node  and spleen cells obtained from donors 3 wk after immuniza- 
tion with 50 #g of BGG in CFA or saline in CFA. 
All recipients received DNPT-OVA for primary immunization 3 wks prior to cell transfer 
and were  boosted with DNP~s-BGG.  Interval refers  to the time between  cell transfer and 
secondary immunization. 
§ The data are expressed as geometric means. A comparison  of the geometric mean anti- 
DNP serum antibody concentrations of groups  A and B, on day 11, yielded a  p  value of 
0.1 >  p >  0.05. A comparison of the geometric means of groups C and D, on day 7, yielded a 
p  value of <0.01. 
[[ Represents the increase in mean antibody levels from day 0 to day 11 (Groups A and B) 
or day 7 (Groups C and D). 
¶ N.D., not determined. 
toneally 4  hr  later). Animals were bled just prior to secondary immunization 
(day 0) and 4, 7, and 11 days later. 
The results of these experiments are presented in Tables I  and II and Fig. 1. 
Guinea pigs which  received  1.0-1.6  X  109  ceils from BGG-sensitized  donors 
displayed secondary  anti-DNP  responses  to immunization  with  DNP2s-BGG 
(Table I, Groups A  and C); a secondary anti-BGG response was also observed 
in  these  animals.  When  secondary immunization  was  performed  1  day  after 
cell transfer, the secondary anti-DNP response was not apparent until day 11 
(Table I,  Group  A).  However,  guinea  pigs which  were  boosted  6  days  after 
transfer manifested clear secondary responses by day 7 after challenge  (Table 
I,  Group  C  and  Fig.  1).  In  contrast,  guinea  pigs  which  received  cells from 
donors sensitized to CFA only, did not  manifest secondary responses to either 
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TABLE  II 
Enhancement  of  Hapten-Specific  Anamnestic  Responses  in  Guinea  Pigs  Following  Passive 
Transfer of Carrier Specific Syngeneic Cells* 
Protocol*  Anti-DNP Antibody  ~g/ml)§ 
Number of cells  Number  of 
Group  Specificity  of  transferred  animals  Day 0  Day 7  Boost/I 
cells transferred 
A  BGG  1000 X  106  3  1.2  57.1  55.9 
B  BGG  200 X  106  3  2.0  29.4  27.4 
C  BGG  50 X  106  4  1.0  13.6  12.6 
D  CFA  200 X  106  4  0.99  0.62  --0,37 
* Lymph node and spleen cells obtained from donors 3 wk after immunization with 50 #g 
of BGG in CFA or saline in CFA. 
All recipients received DNPT-OVA for primary immunization 3 wk prior to cell transfer 
and were boosted with DNP28-BGG 6 days after cell transfer. 
§ The data are expressed as geometric means. A comparison of the geometric mean serum 
anti-DNP antibody concentrations, on day 7, of group D with those of groups A, B, and C 
yielded a p value of <0.01 in each case. Furthermore, a similar comparison for groups A and 
C yielded a p value of <0.05. 
]1 Represents the increase in mean antibody levels from day 0 to day 7. 
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FIG.  1.  Ability of BGG-specific lymphoid cells to prepare DNP-OVA immunized guinea 
pigs for an enhanced response to DNP-BGG. Primary immunization of recipients was per- 
formed at week 0 with 3.0 mg of DNP7-OVA administered intraperitoneally in saline. 3 wk 
later they were transfused with 1.0-1.6  X  109  lymphoid cells from syngeneic donors which 
had been immunized with either 50 #g of BGG in CFA or saline in CFA 3 wk earlier.  6 days 
after cell transfer, the recipients were boosted with 1.0 mg of DNP~s-BGG in saline. Serum 
anti-DNP antibody concentration just prior to challenge and on days 4 and 7 are illustrated. 288  PROPERTIES  OF  CARRIER  CELLS 
The number of BGG-sensitized cells required  to transfer this response was 
shown  to be quite  modest.  Thus,  as shown in Table II, as few as 50  >(  106 
cells from B GG-sensitized donors transferred the capacity to obtain a secondary 
anti-DNP  response  to  DNP28-BGG  when  boosting  was  performed  6  days 
after transfer (Group C). The magnitude of the anti-DNP secondary response 
seemed to be related to the log of the number of cells transferred in the range 
used in  this experiment.  Secondary anti-BGG responses were detectable only 
in the group receiving 1000  )<  106 BGG-sensitized cells (Group A). 
Requirement .for imm~nogenicity  to mediate  carrier function.--An  autosomal 
dominant  gene  (PLL  gene)  exists in  guinea pigs which  controls the  immune 
response to PLL,  GL,  and their haptenic derivatives as well  to several other 
compounds (16).  Strain 2 guinea pigs possess the PLL gene, whereas strain 13 
guinea pigs lack this gene. Thus, strain 13 guinea pigs fail to display an immune 
response to GL. 
In order to determine whether  the capacity to mediate carrier function re- 
quires  that  a  compound  be  immunogenic  by  conventionol  standards  both 
strain  2  and  strain  13  guinea  pigs,  which  had  been  immunized  with  DNPT- 
OVA  1 wk earlier,  were immunized with  100 #g of GL emulsified in  CFA.  3 
wk later a  secondary immunization  with  1.0  mg of DNP20-GL in  saline  was 
performed.  The  strain  2  guinea  pigs displayed  the  expected secondary anti- 
DNP response, whereas the strain  13  animals did not manifest any response, 
and their anti-DNP  antibody concentration fell markedly (Fig.  2). As a  con- 
trol, a group of strain 13 guinea pigs, which had been sensitized to DNPT-OVA, 
were immunized with 50 ~g of BGG in CFA and boosted with 1.0 mg of DNP2s- 
BGG.  These  animals  showed  marked  secondary anti-DNP  responses,  as  ex- 
pected. 
Thus, the locus of action of the product of the PLL gene appears to involve 
a step in the immune response required  for the expression of carrier function. 
Specific immunologic tolerance and carrier function.--In order to determine if 
the carrier function for an antigen could be abrogated by the establishment of 
tolerance  to  that  substance,  a  group  of  rabbits  were  rendered  specifically 
tolerant  to BGG in  the following manner.  Adult  rabbits received two intra- 
venous injections weekly of aggregate-free BGG which  was obtained by cen- 
trifugation at 105,000  g for 90 rain. The top two-thirds of the supernatant was 
used (17,  18). The doses were 1.0 mg in the 1st wk, 10 mg in the 2nd wk, and a 
single 100 mg dose in the 3rd wk. 1 wk after the final dose, tolerant and control 
rabbits  were  immunized  intravenously with  3.0  mg of DNPT-OVA  in  saline 
on 3 successive days, followed 1 wk later by supplemental immunization with 1 
/zg of BGG emulsified in CFA or with saline in CFA. 4 wk later, they received 
secondary immunization  intraperitonea]]y with  5.0  mg of  either DNPT-OVA 
or DNP2s-BGG in saline. The rabbits in the tolerant groups were only partially 
tolerant  since  their  anti-BGG  responses  were  significantly,  but  not  totally, 
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The protocols  and  results  of these  experiments  are presented  in Table III. 
Tolerant  rabbits  which  received  supplemental  immunization  with  1  /~g  of 
BGG  in  CFA displayed  a  mean  secondary anti-DNP  response  of 8.4  /zg/ml 
(Group  A),  whereas  nontolerant  animals  treated  in  the  same  way showed 
a mean net increase of 273.5 ~g/ml (Group B). Indeed, the response of tolerant 
animals which received the  1 ~g BGG supplemental  immunization was essen- 
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FIG. 2. Requirement for immunogenicity to mediate carrier function. Strain  13 and strain 
2 guinea pigs received a primary immunization with  3.0 mg of DNPT-OVA, administered 
intraperitoneally in saline at week 0.1 wk later supplemental immunization with I00 #g of GL 
emulsified in CFA was carried out. 4 wk after primary immunization, the animals were chal- 
lenged with 1.0 mg of DNP20-GL in saline. Serum anti-DNP antibody  concentration  just 
prior to challenge and on days 4 and 7 are illustrated. The numbers in parentheses refer to the 
numbers of animals in the given groups. 
tially  equivalent  to tolerant  or nontolerant  rabbits  which  had  received  only 
CFA supplemental immunization.  (Groups C  and D, respectively.) 
The  response  of BGG-tolerant  animals  to  a  secondary immunization  with 
I)NPT-OVA  (Group  E)  was  reduced  only  slightly  when  compared  to  non- 
tolerant rabbits (Group F), and this difference was not statistically significant, 
Thus,  specific immunologic tolerance  to an  antigen  prevents  an  animal from 
recognizing that antigen as a carrier. 
Failure  of  immunization  to  haptenic  determinants  to  prepare  for  enhanced 
secondary  responses.--In  the  experiments  thus  far  described  by  this  and  the 
preceding paper (6), it has been shown that presensitization to carrier molecules 
prepares  for  an  enhanced  anti-hapten  antibody  response  to  hapten-carrier 290  PROPERTIES  OF  CARRIER  CELLS 
conjugates.  In  order  to  determine  whether  carrier  function  requires  simply 
preimmunization  to determinants  associated with the boosting hapten on the 
same molecule, a series of experiments were undertaken in which animals were 
preimmunized  with  a  given hapten-carrier  conjugate  and  then  the  antibody 
response to  other  determinants  associated  with  the  same hapten  on  another 
carrier was evaluated. 
(a)  Lack  of  enhancement  of  the  primary  response  to  protein  determinants: 
Strain 2 guinea pigs were immunized with either 50 ~g of DNP2s-BGG in CFA 
or with saline in  CFA.  3  wk later,  primary immunization with  either DNPT- 
OVA or Sulf2,-BGG (200 #g intradermally followed in 4 hr by 800 ]~g intraperi- 
toneally in saline) was carried out. The protocols and data are summarized in 
TABLE III 
Effect of Toleranceto the Secondary Carrier  on Hapten-Specific Anamnestic Responses in Rabbits 
Anti-DNP 
Immunization protocol  Number  antibody 
Group  of  (~g/ml)*  Boost 
animals 
Primary  Supplement  Secondary  Day 0  Day 7 
A, tolerant  DNPT-OVA  BGG-CFA  DNP2s-BGG  6  I. 2  9.6  8.4 
(t/~g) 
B, nontolerant  DNPT-OVA  BGG-CFA  DNP2s-BGG  8  3.4  276.9  273.5 
(t m) 
C, tolerant  DNPT-OVA  CFA  DNPgs-BGG  7  1.8  14.0  12.2 
D, nontolerant  DNPT-OVA  CFA  DNP=s-B GG  15  3.2  12.1  8.9 
E,  tolerant  DNPT-OVA  CFA  DNPT-OVA  5  1.8  68.8  67.0 
F, nontolerant  DNPT-OVA  CFA  DNPT-OVA  10  1.9  136.3  134.4 
* The data are expressed as geometric means. A comparison of the geometric mean serum anti-DNP antibody 
concentrations, on day 7, of groups A and B revealed a p value of <0.01. Comparison of the means of groups A  and 
C, A and D, and E  and F  revealed no significant differences (p values, 0.6,  >  0.% and 0.7 respectively). 
Represents  the increase in mean antibody  levels from day 0 to day 7. 
Table IV.  As  can  be  seen,  the  experiment  was  designed  so  that  one  group 
(Group B)  received  the  same  hapten  for preimmunization  and  primary im- 
munization,  whereas  another  group  (Group D)  received  the  same  carrier  in 
both immunizations. 
As shown in Table IV, the existence of a state of immunity to DNP28-BGG 
did not heighten the anti-OVA antibody response to DNPT-OVA  (Group B). 
On the other hand,  sensitivity to DNP2s-BGG enhanced  significantly the pri- 
mary anti-Sulf response to Su]f29-BGG  (Group D) as compared to the controls 
(Group  C).  Thus,  under  these  conditions  immunization  with  DNP.os-BGG 
results in the clear expression of carrier function by the BGG molecule but not 
by DNP determinants. 
(b)  Lack  of enhancement  of the  secondary  response  to  a  second hapten:  New 
Zealand  white  rabbits  were  immunized  intravenously  with  3  daily  doses  of 
3.0  nag  of DNPT-OVA in saline.  1 wk later,  they received supplemental  im- 
munization with 50 #g of either Sulf29-BGG  in  CFA or of GO in CFA.  4  wk w.  E.  PAUL,  D.  H.  KATZ,  E.  A.  GOIDL~ B.  BENACERRAF  291 
later,  a  secondary  immunization of 5.0  mg of  either DNP27-Sulf16-GO, DNP2s- 
BGG,  Sulf29-BGG,  or DNP~7-GO  in saline was  administered intraperitoneally. 
The  protocols  and  data  are  presented  in Table  V.  Rabbits  which received 
TABLE  IV 
Effect of Hapten Preimmunization on Subsequent Anti-Carrier Response in Guinea Pigs 
Group 
Immunization  protocol 
Preimmunization  Primary 
Anti-OVA  Number  (%binding)*  Anti-Sulf titer~ 
of 
animals  Day 0  Day 7  Day0  Day7 
A  CFA  DNP7-OVA  4  13  10  --  -- 
B  DNP2s-BGG-CFA  DNPT-OVA  5  8  11  --  -- 
(50 #g) 
C  CFA  Sulf29-BGG  5  --  --  0  0 
D  DNP2s-BGG-CFA  Sulf29-BGG  5  --  --  0  42 
(50/~g) 
* The data are expressed as arithmetic means, In a normal secondary response to DNPT- 
OVA, a  1:500 dilution of antiserum was found to bind 89% of 125I-OVA in this assay. 
:~ The data are expressed as arithmetic means. 
TABLE  V 
Lack  of Enhancement  of DNP-Specific  Secondary  Responses  to  DNP-Sulf-GO  in  Rabbits 
Preimmunized to Sulf-BGG 
Group 
Jura- 
Immunization  protocol*  bet  Anti-DNP  antibody (~g/ml)~t 
of 
Supplement  Secondary  ani-  Day 0  Day 7  Boost§ 
mals 
A  Sulf29-BGG-CFA  DNP27-Sulfls-GO  8  0.9  2.9  2.0 
B  Sulf29-BGG-CFA  DNP27-GO  4  2.8  8.6  5.8 
C  Sulfeg-BGG-CFA  DNP28-BGG  5  1.7  2681  2679 
D  GO-CFA  DNP27-GO  5  0.7  1713  1712 
* All  rabbits were  immunized intravenously with  9  mg  of  DNPT-OVA,  in  saline,  dis- 
tributed in 3 daily doses. 1 wk later they received a supplemental immunization with 1 #g of 
the indicated compound emulsified in CFA. 4 wk later they were boosted with 5 mg of the 
indicated conjugate, intraperitoneally. 
The data are expressed as geometric means. A comparison of the geometric mean serum 
anti-DNP antibody concentrations, at day 7, of groups A and C revealed a p value of <0.01; 
the p value for the comparison of groups A and B yield a p value of: 0.3  >  p  >  0.2. 
§ Represents the increase in mean antibody level from day 0 to day 7. 
Sulf29-BGG for supplemental  immunization  followed by boosting with DNP~7- 
GO  (Group  B)  had  a  secondary  anti-DNP  response  of  5.8  /zg/ml,  whereas 
rabbits  boosted  with  DNP2s-BGG  (Group  C)  made  an  anti-DNP  secondary 
response  of  2679  /~g/ml. The  experimental  group, boosted with DNP27-Sulf16- 
GO  (Group A), demonstrated  a  response of only 2.0/zg/ml,  even less than  the 292  PROPERTIES  OF  CARRIER  CELLS 
group boosted with DNP27-GO. As control, it was shown that: (a)  the rabbits 
were indeed primarily immunized against the Sulf hapten, as a  group of these 
animals  challenged  with  SulI2~-BGG showed  an  increase  in  anti-Sulf  titer 
from 0.8  to  915;  and  (b)  rabbits which  received supplemental immunization 
with GO in CFA displayed marked secondary anti-DNP  responses to D NP27-GO 
(Group D).  Thus, prior immunization to  the p-azophenylsulfonic acid group 
TABLE  VI 
Eject of Preimmunization to DNP Determinant on the Enhancement of Anti-Sulf Secondary 
Responses to DNP-Bearing Sulfanilazo Conjugates in Guinea Pigs 
Immunization  protocol* 
Group 
Primary  Supplement  Secondary 
A 
B 
Sulf29-BGG 
Sulf29-B  GG 
Sulf29-BGG 
Sulf29-BGG 
C 
D 
DNPa 0-GPA- 
CFA 
DNPa0-GPA- 
CFA 
DNP30-GPA- 
CFA 
DNP30-GPA- 
CFA 
Sulf92-DNP24-GO 
Sulf21-DNP30-GPA 
Sulh6-DANSYL3~- 
GPA 
Sulf3o-GPA 
Num-  Anti Sulf  I 
}ber of I  antib°d~  titer:~  Boost§ 
6  1.7  0  0 
8  2.5  10.5  8.0 
5  1.2  0.4  0 
5  4.4  1.2  0 
* Strain  2 guinea pigs were immunized intraperitoneally  with  3 mg of  Sulf29-BGG in 
saline, distributed  in 3 daily doses. 1 wk later  they received a supplemental immunization 
with 50 #g of DNP30-GPA, emulsified  in CFA and 3 wk later they were boosted with 1 m  of 
the indicated  conjugate  (200 #g intradermally  followed by 800 #g intraperitoneally  4 hr 
later). 
:~ Reciprocal  of  highest  dilution  of  serum  yielding  agglutination  of  Sulfanilazo-sheep 
erythrocytes.  Data are arithmetic means. A comparison of the arithmetic mean serum anti- 
sulf antibody titers at day 7, of groups A and B revealed of p value of <0.05.  Comparisons 
for groups B and C, and B and D showed a p value of 0.1 >  p >  0.5 for both. 
§ Increase in mean titers between days 0 and 7. 
did  not  prepare  for  augmented secondary  anti-DNP  antibody responses  to 
DNP27-Sulf16-GO. 
A  similar lack of effectiveness of hapten presensitization to  enhance second- 
ary  responsiveness to  a  different  hapten  was  observed  in  strain  2  guinea 
pigs.  Four groups of animals were immunized with 3  daily doses of  1.0  mg of 
Sulf29-BGG adminstered intraperitoneally in saline. 1 wk later, they received a 
supplemental immunization with  50  #g  of  DNP30-GPA  emulsified  in  CFA. 
3  wk later,  the guinea pigs were boosted with  1.0 mg of  a  Sulf-protein. The 
protocols and data  are  summarized in Table VI.  Both  Sulf92-DNP24-GO and 
Sulf30-GPA failed  to  elicit detectable  secondary  anti-Sulf responses  (Groups 
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increase in anti-Sulf  antibody  titer  (Group B). This finding is of interest not 
only in that it again confirms the failure of hapten preimmunization to prepare 
for  an  enhanced  secondary  response  but  also  that  it  demonstrates  that  the 
immune response  accorded  to  a haptenic  conjugate  of  an  autologous protein 
(DNP-GPA)  does prepare for an enhanced secondary response to a Sulf deriva- 
tive  of  this  hapten-protein  conjugate  (Sulf21-DNP30-GPA).  The  failure  of 
Sulf16-DANSYL3~-GPA  to  elicit a  secondary  anti-Sulf  response suggests  that 
the  carrier-specific  ceils,  indeed,  are  appreciating  the  presence  of  the  DNP 
group  and  not  simply  a  general  alteration  in  GPA  imposed  by  substituting 
TABLE  VII 
Relative Effectiveness of the Dansyl Group and PLL in Enhancing Secondary Anti-DNP 
Responses in Dansyl-PLL Preimmunized Guinea Pigs 
Group 
Immunization protocol* 
Primary  Supplement  Secondary 
Number  Anti-DNP Antibody 
of  02g/ml):[: 
Animals  Day 0  Day 7  Boost§ 
A  DNPT-OVA  DANSYL2s-PLL-  DNPa74-DANSYLsl-  ,5  1.8  0.6  -- 1.2 
CFA  PDL 
B  DNP~-OVA  DANSYL28-PLL-  DNP3s-PLL  5  2.2  52.1  49.9 
CFA 
C  DNPT-OVA  DANSYL2s-PLL-  DNP~3-DANSYL12-  5  1.0  635  634 
CFA  PLL 
D  DNPT-OVA  DANSYL2s-PLL-  DNP79-PDL  5  1,6  0.5  -- 1.1 
CFA 
* Strain 2 guinea pigs were immunized with 3.0 mg of DNPT-OVA in saline, intraperitoneally,  distributed in 
3 daily doses. 1 wk later they received a supplemental immunization with 50 #g of DANSYL28-PLL, emulsified 
in CFA, and 3 wk later they were boosted with 1 mg of the indicated conjugate  (200/zg intradermally  followed 
by 800 #g intraperltoneally  4 hr later). 
** The data are expressed as geometric means.  Comparisons  of geometric mean serum anti-DNP  antibody 
concentration,  at day 7, for group A with the mean of group B  and C, respectively,  yielded p  values  of  <0.01 
in both instances. In addition, a comparison of the geometric means of groups B and C yielded a p value of  <0.01. 
§ Represents the increase in mean antibody level from day 0 to day 7. 
many groups on the e-amino functions of lysines. Thus, one has a situation in 
which the DNP group plays a necessary, but insufficient, role in antigen car- 
rier cell interactions. 
One might  argue  that  the  capacity  of preimmunization with  a  protein  to 
prepare for enhanced secondary responsiveness and the failure of preimmuniza- 
tion with hapten,  conjugated  to  a  protein not  used  again for immunization, 
could be  explained by  the great diversity  of  antigenic  groups on proteins in 
contradistinction  to  the  large  number  of  similar  haptenic-groups  in  hapten 
conjugates.  In order to test this hypothesis,  supplemental immunization with 
hapten conjugates of a very simple immunogen, poly-L-lysine, was resorted to, 
and the relative efficacy of the hapten (in this case DANSYL)  and the carrier 
(PLL)  in enhancing subsequent secondary responses were compared. 
Four groups of strain 2 guinea pigs were immunized intraperitoneally with 294  PROPERTIES  OF  CARRIER  CELLS 
3 daily doses of 1.0 mg of DNPT-OVA in saline.  Supplemental immunization 
with .50 vg of DANSYL2s-PLL in CFA was carried out 1 wk later. 3 wk later, 
they were challenged with 1.0 mg of either DNPas-PLL, DNP79-PDL, DNP2a- 
DANSYLI~-PLL, or DNP174-DANSYL81-PDL.  Thus,  in the case  of challenge 
with  DNPas-PLL, the  effectiveness  of  carrier  preimmunization  was  being 
evaluated,  whereas  the  effectiveness of hapten  (DANSYL)  preimmunization 
was  being evaluated in the case of the boost with DNP~74-DANSYLs~-PDL. 
Because PDL has physical properties similar  to PLL, it was  employed as  a 
nonimmunogenic or weakly immunogenic carrier for the DNP and DANSVL 
haptens. 
A  summary of the protocols and data for these experiments is presented in 
Table VII. A marked secondary anti-DNP response was obtained to DNP,~5- 
PLL  (Group B),  whereas  no  response was  obtained  to  DNP174-DANSYLs,- 
PDL  (Group  A).  However,  the  secondary  anti-DNP  response  to  DNPea- 
DANSYL12-PLL (Group C) was considerably greater than that to DNPas-PLL, 
again  demonstrating  the  participation  of  hapten  in  antigen  recognition by 
carrier cells. Finally, no response was obtained to DNP79-PDL (Group D). 
One should note that DNPm-DANSYLsI-PDL did not elicit an  anti-DNP 
response despite  the  fact that  it  was  more heavily substituted  with  respect 
to both DNP  and DANS¥'L groups than  was  the  corresponding t-polymer, 
which might have been expected to favor its binding by hapten-specific cells. 
DISCUSSION 
Lymphoid cells  from strain 2 guinea pigs immunized to BGG can transfer 
to  syngeneic  recipients  primed  with  DNP-OVA  the  capacity  to  mount  an 
enhanced  secondary anti-DNP  response  to  DNP-BGG.  This  effect was  ob- 
tained with as few as 50 X  10  6 lymph node and spleen cells which suggests that 
"carrier-specific cells" are, relatively, quite abundant or very efficient. A similar 
conclusion has  been  reached by Mitchison  in  studies  of adoptive secondary 
responses in mice (7). In our experiments, successful transfer of this response is 
obtained when secondary challenge is administered 1 day after transfer; how- 
ever, the response is considerably better 6 days after transfer. It seems unlikely 
that  this difference is  due to proliferation of the transferred cells,  as  the re- 
cipients have not been irradiated and no antigenic stimulus was applied during 
this period. It is, perhaps, more probable that it reflects a need for the cells to 
reach some special anatomic location to perform this function. However, this 
explanation is not wholly satisfying either, and studies are currently in progress 
in an attempt to clarify the events during this period. 
It has been known since the  studies of Landsteiner that  individual  deter- 
minants by themselves do not elicit significant immune responses; association 
of these determinants  with  carrier molecules, however, leads  to an antibody 
response  which  displays  a  significant  degree of hapten  specificity (19).  The W.  E.  PAUL,  D.  H.  KATZ,  E.  A.  GOIDL,  B.  BENACERRAF  295 
role played by the carrier molecule (hereafter referred to as carrier function) 
may have two  interpretations.  On  the  one hand,  the  carrier malecule  may 
simply be a  vehicle for  the association of several similar,  or different deter- 
minants;  this in turn,  presumes that more than one determinant is required 
for  the  initiation  of  immune  responses.  Alternatively,  the  carrier  molecule 
may be independently recognized by a certain cell class Oil the basis of proper- 
ties  independent  of  conventional  antigenic  determinants.  This  recognition 
would be regarded as required for subsequent stimulation of synthesis of anti- 
bodies directed against the determinants which the carrier bears. Indeed, it is 
already very likely that carrier function involves the activity of a different cell 
type than does the synthesis and secretion of humoral antibodies (7). 
The results of the experiments presented in this paper may be considered in 
the light of these alternatives. 
Several biologic  characteristics  of  the  carrier function have  been  demon- 
strated. Specific immunologic tolerance to BGG prevents immunization to BGG 
from  enhancing  a  subsequent  secondary  anti-DNP  response  to  DNP-BGG 
in  rabbits.  Thus,  the  ceils  mediating  carrier function  are  capable  of  being 
rendered immunologically tolerant. This may well be analogous to the state of 
specific immunologic  tolerance  to  bovine  serum  albumin  induced  in  mouse 
thymus ceils as reported by Taylor (20), 
Certain characteristics of the functional specificity of carrier cells have also 
been explored. First, we have shown that guinea pigs genetically incapable of 
making  a  complete immune response to  a  copolymer of L-glutamic acid and 
L-lysine  (GL)  fail  to  develop  an  enhanced  secondary  anti-hapten  response 
after supplemental immunization with GL. Indeed these animsls,  which had 
been primed with DNP-OVA, made no secondary response whatever to DNP- 
GL. This shows that carrier function is not exercised on nonimmunogens even 
though they may bear multiple haptenic determinants. 
It  was  not  unexpected,  therefore,  that  preimmunization  to  haptenic  de- 
terminants did not result in the expression of carrier function, at least in the 
experimental  systems  employed here.  Indeed,  neither  the  primary  immune 
response to ovalbumin in guinea pigs nor the secondary immune response to 
the sulfanil determinant in rabbits or to DNP in guinea pigs were enhanced by 
boosting with heterologous conjugates which contained a hapten to which the 
animal had been immunized. However, haptens may contribute to determinants 
recognized by cells  which mediate carrier function. This is demonstrated by 
the findings than DANSYL-PLL is superior to PLL as  a  carrier in  animals 
preimmunized with DANSYL-PLL, and that DNP-GPA is similarly superior 
to both  GPA  and DANSYL-GPA in DNP-GPA preimmunized guinea pigs. 
The objection may be raised to this interpretation that  conjugation imparts 
an  alteration in  the  protein or polypeptide which  is  crucial  in  immunologic 
terms. While it is undoubtedly true that the conformation of proteins is altered 296  PROPERTIES  OF  CARRIER  CELLS 
as a result of conjugation (21-24), it does not seem likely that such new deter- 
minants should be appreciated by carrier-specific cells but the haptens them- 
selves not so appreciated. Furthermore, if alterations are important, they must 
be rather specific, for in a DNP-GPA preimmunized guinea pig Sulf-DANSYL- 
GPA  fails  to  enhance  the  secondary  response  to  Sulf,  whereas  Sulf-DNP- 
GPA does.  Thus,  the cells would have to distinguish  alterations induced by 
two haptens both of which are mainly substituted on e-amino groups of lysine. 
Finally,  the fact that a  homopolymer of L-lysine (PLL) is a  carrier suggests 
that  antigenic  complexity, in  the  sense of the  possession  of many antigenic 
determinants of different specificity, is not  the crucial feature for expression" 
of carrier function. 
Indeed, the attempt to obtain enhanced secondary responses by hapten pre- 
immunization was perhaps naive. If such effects could be easily obtained then 
one would never have expected carrier specificity of hapten-specific antibody 
responses to have been described in the first place. It should, nevertheless, be 
pointed  out  that  Mitehison  has  reported  marginal  enhancement  in  such  a 
hapten preimmunization system in mice (7, 25). 
One  may then consider why haptenic  determinants fail  to express carrier 
function, or do so only marginally, although they can participate in the specific- 
ity of the cells which mediate carrier function. Three general explanations may 
be entertained: 
(a)  Cells mediating carrier function,  as a  class,  have  antigen-sensitive re- 
ceptors generally similar to those of the  precursors of antibody forming cells; 
however, the receptors of the former cells differ from those of the latter in their 
range of specificity, inasmuch  as  they are specialized to recognize the deter- 
minant~ of native and of altered proteins and polypeptides. 
(b) Cells mediating carrier function generally possess receptors of low affinity 
relative to the  concentration conditions  in  their environment,  and  can bind 
and be activated by exposure to a total antigenic determinant and only rarely 
by the partial determinant which haptens constitute. 
(c)  Cells  mediating carrier function are specialized either in  the possession 
of an entirely different class of recognition units  or in the normal  binding of 
antigen followed by an additional  operation which can only be performed on 
substrates of given structure. 
Evidence presented here and previously (26)  that carrier function is under 
a simple genetic control may be considered an argument against the notion that 
carrier function  is  simply  mediated  by multiple  determinants  on  the  same 
backbone. The failure of DNP-DANSYL-PDL to enhance anti-DNP secondary 
responses in DANSYL-PLL immunized animals is an important point against 
the latter view, especially considering that the high degree of substitution of 
both  haptens  should  favor  cooperative interactions  with  cellular  receptors. 
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to be identical  to those  of antigens  and sensitized cells in  the  elicitation of 
delayed hypersensitivity and its in vitro correlates. 
As discussed in the previous paper and elsewhere (6, 7, 20), carrier function 
in the synthesis of anti-hapten  antibody in response to hapten-carrier immu- 
nization may be  analogous to the requirement for thymus dependent cells in 
the  anti-sheep  erythrocyte antibody synthesis by  the  bone  marrow  derived 
lymphoid cells of mice (27-30). These phenomena may well reflect an essential 
process in all immune responses. 
SUMMARY 
Transfer of live lymphoid cells from BGG-immunized strain  2 guinea pigs 
into syngeneic animals primed with DNP-OVA  prepares the recipients for a 
markedly  enhanced  secondary anti-DNP  antibody response upon  challenge 
with DNP-BGG. This phenomenon has been demonstrated when the recipients 
were challenged 1 day after cell transfer, but it was considerably more striking 
when an interval of 6 days was allowed between transfer of cells and challenge 
with  antigen. 
As  demonstrated  in  the  preceding  paper  (6),  BGG  preimmunization  en- 
hanced anti-DNP  antibody responses to challenge with DNP-BGG. An anal- 
ysis of the characteristics  of  substances  to  which  preimmunization  was  ef- 
fective in enhancing subsequent anti-hapten responses was made. It was shown 
that preimmunization of strain  13 guinea pigs with a  copolymer of glutamic 
acid and lysine (GL), to which these animals are genetically unable to accord 
an  immune response,  failed to prepare  them for an  enhanced anti-DNP  re- 
sponse to DNP-GL. Tolerance to BGG specifically abrogated the capacity of 
subsequent BGG immunization to prepare DNP-OVA  primed rabbits for an 
enhanced anti-DNP response to DNP-BGG. 
Sensitization of animals  to haptens  by preimmunization with  hapten-pro- 
tein  conjugates  failed  to  prepare  them  for  enhanced  primary or  secondary 
antibody responses  to other determinants  associated  with  that  hapten  on  a 
different carrier. 
These  studies  indicate  that  the  enhancing  effect of  carrier  preimmuniza- 
tion  reflects  a  cooperative  interaction  between  lymphoid  cells  specific  for 
carrier  and  cells  specialized  for  haptenic  determinants.  Furthermore,  the 
capacity of a substance to behave as a carrier requires more than its possession 
of a variety of antigenic determinants. 
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